23G transconjunctival sutureless vitrectomy safe & effective

Article

Twenty-three gauge transconjunctival sutureless vitrectomy is an effective surgical technique for the management of vitreoretinal diseases.

Twenty-three gauge transconjunctival sutureless vitrectomy is an effective surgical technique for the management of vitreoretinal diseases, according to a study published in the February issue of Retina.

Asheesh Tewari and colleagues from the Kresge Eye Institute, Wayne State University School of Medicine, Michigan, US conducted a retrospective chart review of 81 consecutive 23-gauge vitrectomy cases carried out by a single surgeon for various posterior segment conditions.

Mean follow-up was 6.5 months (range: three to nine months). Mean preoperative visual acuity (VA) was 20/150 and final VA was 20/70 (p<0.0001). Mean intraocular pressure (IOP) on the first day postoperatively was 14 mmHg (range: 6 - 28 mmHg). There was a single case of intraoperative retinal tear that required treatment with cryotherapy and 20 eyes of 48 phakic eyes (42%) had worsening cataracts during the postoperative period. There were no recorded cases of endophthalmitis or retinal detachment.

It was the conclusion of the researchers that 23-gauge transconjunctival sutureless vitrectomy is both safe and effective.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.